159 related articles for article (PubMed ID: 37794855)
1. Long-term Effects of Gastric Acid Prophylaxis in Kidney Transplant Recipients.
Yazici H; Oto OA; Mirioglu S; Dirim AB; Demir E; Uludag O; Akardere OF; Caliskan Y; Lentine KL
Rev Nefrol Dial Transpl; 2023; 43(3):156-166. PubMed ID: 37794855
[TBL] [Abstract][Full Text] [Related]
2. Comparing safety of proton-pump inhibitors versus H2-receptor antagonists in kidney transplant recipients: A systematic review and meta-analysis.
Mohammadi K; Yaribash S; Razi B; Dashti-Khavidaki S
J Clin Pharm Ther; 2022 May; 47(5):567-574. PubMed ID: 34931328
[TBL] [Abstract][Full Text] [Related]
3. Renal Transplant Acute Rejection with Lower Mycophenolate Mofetil Dosing and Proton Pump Inhibitors or Histamine-2 Receptor Antagonists.
Patel KS; Stephany BR; Barnes JF; Bauer SR; Spinner ML
Pharmacotherapy; 2017 Dec; 37(12):1507-1515. PubMed ID: 28976570
[TBL] [Abstract][Full Text] [Related]
4. Proton Pump Inhibitors Independently Protect Against Early Allograft Injury or Chronic Rejection After Lung Transplantation.
Lo WK; Goldberg HJ; Boukedes S; Burakoff R; Chan WW
Dig Dis Sci; 2018 Feb; 63(2):403-410. PubMed ID: 29094310
[TBL] [Abstract][Full Text] [Related]
5. Proton pump inhibitors and adverse effects in kidney transplant recipients: A meta-analysis.
Boonpheng B; Thongprayoon C; Bathini T; Sharma K; Mao MA; Cheungpasitporn W
World J Transplant; 2019 Jun; 9(2):35-47. PubMed ID: 31363460
[TBL] [Abstract][Full Text] [Related]
6. Risk of post-stroke pneumonia with proton pump inhibitors, H2 receptor antagonists and mucoprotective agents: A retrospective nationwide cohort study.
Song TJ; Kim J
PLoS One; 2019; 14(5):e0216750. PubMed ID: 31067267
[TBL] [Abstract][Full Text] [Related]
7. Interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care units.
Toews I; George AT; Peter JV; Kirubakaran R; Fontes LES; Ezekiel JPB; Meerpohl JJ
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD008687. PubMed ID: 29862492
[TBL] [Abstract][Full Text] [Related]
8. Choice of Acid Suppressant Therapy and Long-Term Graft Outcomes After Kidney Transplantation.
January SE; Progar K; Nesselhauf NM; Hagopian JC; Malone AF
Pharmacotherapy; 2020 Nov; 40(11):1082-1088. PubMed ID: 33037663
[TBL] [Abstract][Full Text] [Related]
9. Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients.
Hill P; Cross NB; Barnett AN; Palmer SC; Webster AC
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004759. PubMed ID: 28073178
[TBL] [Abstract][Full Text] [Related]
10. Routine prophylaxis with proton pump inhibitors and post-transplant complications in kidney transplant recipients undergoing early corticosteroid withdrawal.
Courson AY; Lee JR; Aull MJ; Lee JH; Kapur S; McDermott JK
Clin Transplant; 2016 Jun; 30(6):694-702. PubMed ID: 27004722
[TBL] [Abstract][Full Text] [Related]
11. A Comparison of Histamine Receptor Antagonists Versus Proton Pump Inhibitor Gastrointestinal Ulcer Prophylaxis in Kidney Transplant Recipients.
Rouse GE; Hardinger K; Tsapepas D; Tichy EM
Prog Transplant; 2017 Mar; 27(1):4-9. PubMed ID: 27650918
[TBL] [Abstract][Full Text] [Related]
12. Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients.
Hahn D; Hodson EM; Hamiwka LA; Lee VW; Chapman JR; Craig JC; Webster AC
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD004290. PubMed ID: 31840244
[TBL] [Abstract][Full Text] [Related]
13. Proton Pump Inhibitor Use, Fatigue, and Health-Related Quality of Life in Kidney Transplant Recipients: Results From the TransplantLines Biobank and Cohort Study.
Knobbe TJ; Kremer D; Douwes RM; Eisenga MF; Gomes-Neto AW; Annema C; Swarte JC; Klont F; Navis G; Berger SP; Bakker SJL;
Am J Kidney Dis; 2023 Aug; 82(2):189-201.e1. PubMed ID: 36801431
[TBL] [Abstract][Full Text] [Related]
14. [Are proton pump inhibitors superior to H2 receptor antagonists within the scope of H. pylori eradication therapy? Meta analysis of current parallel group comparisons].
Holtmann G; Layer P; Goebell H
Z Gastroenterol; 1996 May; 34(5):267-72. PubMed ID: 8686357
[TBL] [Abstract][Full Text] [Related]
15. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
[TBL] [Abstract][Full Text] [Related]
16. Trends in prescribing H2-receptor antagonists and proton pump inhibitors in primary care.
Martin RM; Lim AG; Kerry SM; Hilton SR
Aliment Pharmacol Ther; 1998 Aug; 12(8):797-805. PubMed ID: 9726394
[TBL] [Abstract][Full Text] [Related]
17. What is the optimum prophylaxis against gastrointestinal haemorrhage for patients undergoing adult cardiac surgery: histamine receptor antagonists, or proton-pump inhibitors?
Patel AJ; Som R
Interact Cardiovasc Thorac Surg; 2013 Mar; 16(3):356-60. PubMed ID: 23208652
[TBL] [Abstract][Full Text] [Related]
18. Concomitant proton pump inhibitors with mycophenolate mofetil and the risk of rejection in kidney transplant recipients.
Knorr JP; Sjeime M; Braitman LE; Jawa P; Zaki R; Ortiz J
Transplantation; 2014 Mar; 97(5):518-24. PubMed ID: 24162246
[TBL] [Abstract][Full Text] [Related]
19. The effect of rabeprazole alone or in combination with H2 receptor blocker on intragastric pH: a pilot study.
Törüner M; Bektaş M; Cetinkaya H; Soykan I; Ozden A
Turk J Gastroenterol; 2004 Dec; 15(4):225-8. PubMed ID: 16249975
[TBL] [Abstract][Full Text] [Related]
20. Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant recipients.
Webster AC; Wu S; Tallapragada K; Park MY; Chapman JR; Carr SJ
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD004756. PubMed ID: 28731207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]